Virtus ETF Advisers’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,802
| Closed | -$70.6K | – | 675 |
|
|
2024
Q4 | $70.6K | Sell |
1,802
-623
| -26% | -$24.4K | 0.03% | 372 |
|
|
2024
Q3 | $95.5K | Buy |
2,425
+45
| +2% | +$1.77K | 0.04% | 383 |
|
|
2024
Q2 | $92.8K | Buy |
2,380
+277
| +13% | +$10.8K | 0.05% | 346 |
|
|
2024
Q1 | $90.5K | Sell |
2,103
-142
| -6% | -$6.11K | 0.05% | 381 |
|
|
2023
Q4 | $103K | Sell |
2,245
-79
| -3% | -$3.64K | 0.07% | 346 |
|
|
2023
Q3 | $79.4K | Sell |
2,324
-228
| -9% | -$7.79K | 0.05% | 362 |
|
|
2023
Q2 | $98.3K | Sell |
2,552
-58
| -2% | -$2.23K | 0.06% | 392 |
|
|
2023
Q1 | $93.4K | Sell |
2,610
-1,006
| -28% | -$36K | 0.05% | 352 |
|
|
2022
Q4 | $143K | Sell |
3,616
-57
| -2% | -$2.25K | 0.07% | 358 |
|
|
2022
Q3 | $133K | Buy |
3,673
+30
| +0.8% | +$1.09K | 0.05% | 373 |
|
|
2022
Q2 | $111K | Sell |
3,643
-2,435
| -40% | -$74.2K | 0.04% | 406 |
|
|
2022
Q1 | $186K | Sell |
6,078
-361
| -6% | -$11K | 0.08% | 202 |
|
|
2021
Q4 | $201K | Sell |
6,439
-5,055
| -44% | -$158K | 0.08% | 208 |
|
|
2021
Q3 | $176K | Sell |
11,494
-597
| -5% | -$9.14K | 0.08% | 300 |
|
|
2021
Q2 | $225K | Sell |
12,091
-12,728
| -51% | -$237K | 0.09% | 260 |
|
|
2021
Q1 | $444K | Buy |
24,819
+438
| +2% | +$7.84K | 0.19% | 165 |
|
|
2020
Q4 | $375K | Sell |
24,381
-1,292
| -5% | -$19.9K | 0.16% | 162 |
|
|
2020
Q3 | $284K | Sell |
25,673
-3,497
| -12% | -$38.7K | 0.15% | 236 |
|
|
2020
Q2 | $366K | Buy |
+29,170
| New | +$366K | 0.17% | 246 |
|